Evidence map›Paper›PMID 38838675›Full record

ArticleCell host & microbe2024

Epithelial hypoxia maintains colonization resistance against Candida albicans.

Hannah P Savage, Derek J Bays, Connor R Tiffany, Mariela A F Gonzalez, Eli J Bejarano, Thaynara P Carvalho, Zheng Luo, Hugo L P Masson, Henry Nguyen, Renato L Santos and 3 more

Abstract read
In one paragraph

Article in Cell host & microbe, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. PPARMolecular nutrition & food research · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. EnterohemorrhagiciScience · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. microLife · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Hannah P SavageDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA.
Derek J BaysDepartment of Internal Medicine, Division of Infectious Diseases, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Connor R TiffanyDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA.
Mariela A F GonzalezDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA.
Eli J BejaranoDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA.
Thaynara P CarvalhoDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA; Departamento de Clinica e Cirurgia Veterinárias, Escola de Veterinária da Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627 Belo Horizonte, MG, Brazil.
Zheng LuoDepartment of Pathology Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA.
Hugo L P MassonDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA.
Henry NguyenDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA.
Renato L SantosDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA; Departamento de Clinica e Cirurgia Veterinárias, Escola de Veterinária da Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627 Belo Horizonte, MG, Brazil.
Krystle L ReaganDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA 95615, USA.
George R ThompsonDepartment of Internal Medicine, Division of Infectious Diseases, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Andreas J BäumlerDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA 95616, USA. Electronic address: ajbaumler@ucdavis.edu.

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
UC Davis Clinical and Translational Science CenterUL1TR000002 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$12.2M
Virulence Factors of SalmonellaR01AI044170 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMLER, ANDREAS J · 1999 to 2022
$8.5M
Exacerbation of colitis by the microbiotaR01AI112445 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler · 2015 to 2026
$6.2M
Microbiota Outgrowth by SalmonellaR01AI096528 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2011 to 2025
$6.1M
Mechanism of Colonization ResistanceR01AI112949 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler · 2016 to 2026
$5.2M
Interspecies microbial interactions in CKDR01DK138912 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler, Sebastian E Winter · 2024 to 2026
$2.1M
UC Davis Clinical and Translational Science CenterTL1TR000133 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$594k
Dietary copper reconfigures pathogen growthR21AI146432 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2019 to 2020
$432k
Citrobacter illuminates the mechanistic underpinnings of gut biogeographyR21AI153069 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2020 to 2021
$413k
Mechanism of E. coli colonization resistanceR56AI112949 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2014 to 2014
$382k
Development of Faux-Biotics to combat the spread of hospital-acquired antibiotic-resistant infectionsF32AI161850 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SAVAGE, HANNAH P · 2021 to 2022
$136k
NCATS NIH HHS TL1 TR000133NCATS NIH HHS UL1 TR000002NCATS NIH HHS UL1 TR001860NIAID NIH HHS F32 AI161850NIAID NIH HHS R01 AI044170NIAID NIH HHS R01 AI096528NIAID NIH HHS R01 AI112445NIAID NIH HHS R01 AI112949NIAID NIH HHS R21 AI146432NIAID NIH HHS R21 AI153069NIAID NIH HHS R56 AI112949NIDDK NIH HHS R01 DK138912
6 · The paper itself

Abstract

Antibiotic treatment promotes the outgrowth of intestinal Candida albicans, but the mechanisms driving this fungal bloom remain incompletely understood. We identify oxygen as a resource required for post-antibiotic C. albicans expansion. C. albicans depleted simple sugars in the ceca of gnotobiotic mice but required oxygen to grow on these resources in vitro, pointing to anaerobiosis as a potential factor limiting growth in the gut. Clostridia species limit oxygen availability in the large intestine by producing butyrate, which activates peroxisome proliferator-activated receptor gamma (PPAR-γ) signaling to maintain epithelial hypoxia. Streptomycin treatment depleted Clostridia-derived butyrate to increase epithelial oxygenation, but the PPAR-γ agonist 5-aminosalicylic acid (5-ASA) functionally replaced Clostridia species to restore epithelial hypoxia and colonization resistance against C. albicans. Additionally, probiotic Escherichia coli required oxygen respiration to prevent a post-antibiotic bloom of C. albicans, further supporting the role of oxygen in colonization resistance. We conclude that limited access to oxygen maintains colonization resistance against C. albicans.

Indexed as

Candida albicansOxygenAnaerobiosisAnimalsAnti-Bacterial AgentsCandidiasisCecumEscherichia coliGerm-Free LifeHumansHypoxiaIntestinal MucosaMiceMice, Inbred C57BLPPAR gammaStreptomycinAnti-Bacterial AgentsOxygenPPAR gammaStreptomycinCandida albicansClostridiacolonization resistanceepithelial hypoxiaEscherichia coli

Identifiers

PMID38838675
PMCPMC11239274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.